4.5 Review

Adenosine-associated delivery systems

期刊

JOURNAL OF DRUG TARGETING
卷 23, 期 7-8, 页码 580-596

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/1061186X.2015.1058803

关键词

Adenosine; controlled drug delivery; controlled release; drug delivery; drug targeting; nanoparticles; targeted drug delivery

资金

  1. National Science Foundation [EFRI-1240443]
  2. IMMODGEL [602694]
  3. National Institutes of Health [EB012597, AR057837, DE021468, HL099073, AI105024, AR063745]

向作者/读者索取更多资源

Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosine's extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据